Bojar RA - Search Results

1

Bojar RA, Holland KT. Bojar RA, et al. Clin Dermatol. 2004 Sep-Oct;22(5):375-9. doi: 10.1016/j.clindermatol.2004.03.005. Clin Dermatol. 2004. PMID: 15556721 Review.

2

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.

Cunliffe WJ, Holland KT, Bojar R, Levy SF. Cunliffe WJ, et al. Clin Ther. 2002 Jul;24(7):1117-33. doi: 10.1016/s0149-2918(02)80023-6. Clin Ther. 2002. PMID: 12182256 Clinical Trial.

3

Characterisation of cryptic plasmid pPG01 from Propionibacterium granulosum, the first plasmid to be isolated from a member of the cutaneous propionibacteria.

Farrar MD, Howson KM, Emmott JE, Bojar RA, Holland KT. Farrar MD, et al. Among authors: bojar ra. Plasmid. 2007 Jul;58(1):68-75. doi: 10.1016/j.plasmid.2007.01.004. Epub 2007 Mar 13. Plasmid. 2007. PMID: 17360038

4

Genome sequence and analysis of a Propionibacterium acnes bacteriophage.

Farrar MD, Howson KM, Bojar RA, West D, Towler JC, Parry J, Pelton K, Holland KT. Farrar MD, et al. Among authors: bojar ra. J Bacteriol. 2007 Jun;189(11):4161-7. doi: 10.1128/JB.00106-07. Epub 2007 Mar 30. J Bacteriol. 2007. PMID: 17400737 Free PMC article.

5

Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris.

Sommer S, Bojar R, Cunliffe WJ, Holland D, Holland KT, Naags H. Sommer S, et al. Clin Exp Dermatol. 1997 Sep;22(5):211-5. Clin Exp Dermatol. 1997. PMID: 9536540 Clinical Trial.

6

The effect of zinc and erythromycin on the growth of erythromycin-resistant and erythromycin-sensitive isolates of Propionibacterium acnes: an in-vitro study.

Holland KT, Bojar RA, Cunliffe WJ, Cutcliffe AG, Eady EA, Farooq L, Farrell AM, Gribbon EM, Taylor D. Holland KT, et al. Among authors: bojar ra. Br J Dermatol. 1992 May;126(5):505-9. doi: 10.1111/j.1365-2133.1992.tb11826.x. Br J Dermatol. 1992. PMID: 1610692

7

The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37.

Bojar RA, Holland KT, Cunliffe WJ. Bojar RA, et al. J Antimicrob Chemother. 1991 Dec;28(6):843-53. doi: 10.1093/jac/28.6.843. J Antimicrob Chemother. 1991. PMID: 1726169

8

Disruption of the transmembrane pH gradient--a possible mechanism for the antibacterial action of azelaic acid in Propionibacterium acnes and Staphylococcus epidermidis.

Bojar RA, Cunliffe WJ, Holland KT. Bojar RA, et al. J Antimicrob Chemother. 1994 Sep;34(3):321-30. doi: 10.1093/jac/34.3.321. J Antimicrob Chemother. 1994. PMID: 7829407

9

The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora.

Bojar RA, Cunliffe WJ, Holland KT. Bojar RA, et al. Br J Dermatol. 1995 Feb;132(2):204-8. doi: 10.1111/j.1365-2133.1995.tb05014.x. Br J Dermatol. 1995. PMID: 7888356

10

Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc.

Bojar RA, Eady EA, Jones CE, Cunliffe WJ, Holland KT. Bojar RA, et al. Br J Dermatol. 1994 Mar;130(3):329-36. doi: 10.1111/j.1365-2133.1994.tb02929.x. Br J Dermatol. 1994. PMID: 8148274 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page